Latest News

In early March 2026, Lincoln National reported its sixth consecutive quarter of growth in adjusted operating income, with management highlighting broad-based strength across Group Protection, Annuities, Retirement Plan Services, and Life Insurance on its Q4 2025 earnings call. At the same time, analysts at firms such as Wells Fargo and Morgan Stanley reiterated positive views on the insurer, emphasizing improving free cash flow, lower leverage, and clearer prospects for future capital...

Phase 2 UBT251 data puts obesity pipeline in focus United Laboratories International Holdings (SEHK:3933) has drawn fresh attention after its subsidiary completed a Chinese phase 2 trial of UBT251, a GLP-1, GIP and glucagon triple agonist for overweight and obesity. See our latest analysis for United Laboratories International Holdings. The phase 2 obesity data lands at a time when the share price has a 1 month share price return of 11.39% and a year to date share price return of 12.53%,...

In early March 2026, John Wiley & Sons, Inc. reported fiscal third-quarter sales of US$410.04 million, returning to a net income of US$29.68 million and positive earnings per share from continuing operations after a loss in the same period a year earlier. Separately, OpenEvidence announced a partnership to integrate a wide portfolio of Wiley’s peer-reviewed medical and scientific content into its point-of-care platform, highlighting how Wiley’s research assets are being embedded in...

Lennox International (NYSE:LII) has entered the North American water heating market through a joint venture with Ariston Group. The partnership is launching a new line of water heaters, adding to Lennox's existing product portfolio. The move expands Lennox's dealer network and allows contractors to offer integrated HVAC and water heating solutions. Lennox International, best known for residential and commercial HVAC systems, is now stepping into water heating, a closely related category...

If you are wondering whether Tenet Healthcare at around US$236.95 is still offering value after a strong run, or if most of the upside is already priced in, this article is here to help you frame that question clearly. The stock has been volatile recently, with a 1% decline over the last 7 days, a 24.3% gain over the last 30 days, an 18.8% return year to date, an 85.9% return over 1 year, and a very large 3 year and 5 year return. This naturally raises questions about risk, sentiment, and...

CAE (TSX:CAE) is back on investors’ radar after signing a teaming agreement with ThyssenKrupp Marine Systems to support the Canadian Patrol Submarine Project for the Royal Canadian Navy. See our latest analysis for CAE. At a share price of CA$40.25, CAE has seen a 6.43% 90 day share price return, while its 1 year total shareholder return of 11.31% points to steadier gains over time. This may indicate that recent momentum is building off a longer trend. If defense and aerospace training is on...

In early March 2026, Omada Health launched its GLP-1 Flex Care program for employer clients and reported fourth-quarter 2025 revenue of US$75.85 million with net income of US$5.16 million, alongside full-year 2025 revenue of US$260.21 million and reduced annual net loss of US$12.78 million. By combining a cash-pay GLP-1 access model that limits employers’ drug spend with improving profitability metrics, Omada is positioning its virtual care platform as both a cost-control and...

Large investors have been actively reshaping their positions in Turning Point Brands (NYSE:TPB) following the company’s move toward nicotine pouches. Apis Capital Advisors has raised its stake, while Cannell Capital has cut its holdings, with both changes occurring soon after a strong earnings report. These moves highlight differing views on the shift from legacy products to modern oral nicotine and the role of nicotine pouches in TPB’s future. Turning Point Brands, trading at $91.66, has...

IDEX (IEX) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months, prompting a closer look at its current valuation setup. See our latest analysis for IDEX. At around $197.90, IDEX’s recent 1 day and 7 day share price declines of 2.67% and 5.52% sit against a 90 day share price return of 11.47% and year to date share price return of 10.52%. Longer multi year total shareholder returns have been more muted, which...

GlobalFoundries (NasdaqGS:GFS) announced a multi billion dollar manufacturing partnership with Renesas Electronics. The agreement focuses on supplying automotive grade chips, particularly microcontrollers used across vehicles. Production is set to begin in the US, with plans for future capacity expansion in other regions. The partnership is framed as a way to support supply chain security for critical automotive semiconductors. For GlobalFoundries, this deal sits at the intersection of its...

Why Pacific Basin Shipping’s Latest Earnings Matter for Investors Pacific Basin Shipping (SEHK:2343) has just reported its full year 2025 results, with sales of US$2,081.04 million and net income of US$58.17 million, alongside commentary on shareholder returns and capital allocation. The company also pointed to a 46% total shareholder return, a new US$250 million sustainability linked facility, and an ongoing share buyback. Together, these factors frame how management is currently thinking...

In late February, Ares Management filed an omnibus shelf registration covering Class A common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, and units, while also participating in a multi‑billion‑dollar unitranche financing backing Thoma Bravo’s acquisition and merger of WWEX Group and Auctane. These developments came as Ares faced increased scrutiny over private credit risks and an earnings miss, highlighting the tension between its expanding...

How Cigna Group’s Recent Performance Sets Up the Valuation Debate Cigna Group (CI) has drawn investor attention after recent share performance that includes a 3.4% one day decline and a 6.3% drop over the past week, sharpening focus on its current valuation and fundamentals. See our latest analysis for Cigna Group. The recent 1 day share price decline and weak 7 day share price return compare with a year to date share price decline of 2.7% and a 1 year total shareholder return decline of...

Ionis Pharmaceuticals (IONS) is back in focus after the US FDA accepted a Priority Review for its supplemental New Drug Application for olezarsen in severe hypertriglyceridemia, placing a key RNA medicine under a tighter regulatory timeline. See our latest analysis for Ionis Pharmaceuticals. Despite the latest FDA Priority Review, Ionis Pharmaceuticals' recent share price momentum has cooled, with a 30 day share price return of 12.88% and a year to date share price return decline of 7.07%,...

What Symbotic’s latest quarter means for investors Symbotic (SYM) reported a fiscal Q1 that featured revenue near US$630 million and margin expansion as more warehouse automation sites moved into steady operations, drawing fresh attention to the stock. See our latest analysis for Symbotic. Despite a stronger fiscal Q1 narrative, Symbotic’s recent share price has been under pressure, with a 1-day share price return of an 8.63% decline and a year-to-date share price return of a 25.07% decline...

Canadian National Railway recently reported that it moved a record 2.67 million metric tons of grain from Western Canada in February 2026, extending a run of new grain-volume records that included more than 31.3 million metric tons hauled in 2025. This performance, supported by its detailed 2025–2026 Winter Plan, highlights how CN’s operational planning can keep critical agricultural supply chains running efficiently through harsh conditions. Next, we’ll examine how CN’s record February...

With no single headline driving Steel Dynamics (STLD) today, investors are instead weighing its recent performance, including a past 3 months return near 10% and a 1 year total return around 47%. See our latest analysis for Steel Dynamics. At a share price of US$181.61, Steel Dynamics has recently seen a 1 month share price return of about a 9% decline, even though its 1 year total shareholder return is around 47%. This suggests that shorter term momentum looks softer than the longer term...

In recent months, Wheaton Precious Metals reported record Q3 2025 revenue and net earnings growth, underpinned by strong production, higher silver prices, and nearly US$1 billion of new streaming agreements that increased cash flow visibility. This combination of rapid earnings growth, consistent earnings beats, and expanding high-margin streaming deals has prompted analysts to raise their forecasts and express greater confidence in Wheaton’s longer-term outlook. With this backdrop of...

Cibus Nordic Real Estate (OM:CIBUS) has just combined a €60 million perpetual subordinated note issue at a fixed 6.25% coupon with AGM proposals covering monthly dividends, bylaw changes, new share authorizations and employee warrant schemes. See our latest analysis for Cibus Nordic Real Estate. These funding and dividend proposals arrive after a softer patch in the share price, with a 7 day share price return of a 2.84% decline and a 90 day share price return of a 5.68% decline. However, the...

If you are asking yourself whether Ardelyx at around US$6.19 is attractively priced or not, this article is going to walk through what the current market price might be implying about its value. The share price has seen mixed returns, including a 5.5% decline over the last week and a 16.1% decline over the last month, alongside a 16.8% return over the past year and 73.9% over three years. Year to date performance is around 0.7%, and the 5 year return reflects an 11.2% decline. Recent trading...

Why TKH Group’s latest earnings and contract win matter for investors TKH Group (ENXTAM:TWEKA) has landed an eight year, approximately €650 million contract with Dutch grid operator Alliander, shortly after reporting a stronger EBITA result in Q4 2025 that highlighted improved profitability. See our latest analysis for TKH Group. The contract news and stronger Q4 EBITA arrive after a mixed run in the market. A 1 day share price return of 3.29% lifted the price to €37.02. The 1 year total...

Why BAE Systems (LSE:BA.) is on investors’ radar now BAE Systems (LSE:BA.) shares have moved sharply over the past year, with a 44.1% total return and gains across the past month and past 3 months, putting the defense group firmly in focus for investors. See our latest analysis for BAE Systems. BAE Systems’ recent move to a £22.14 share price follows a run of strong momentum, with a 30 day share price return of 18.11% and a 5 year total shareholder return of 410.96%. This suggests investors...

Biogen (NasdaqGS:BIIB) and Stoke Therapeutics reported promising clinical results for zorevunersen in Dravet syndrome, with data highlighting durable seizure reductions and cognitive benefits. The zorevunersen findings were published in The New England Journal of Medicine, supporting its potential as a disease modifying therapy for this rare, severe epilepsy. Biogen released new high dose SPINRAZA data for spinal muscular atrophy, including long term safety and efficacy updates. The company...

If you are wondering whether MarketAxess Holdings at around US$186 still reflects its underlying value, this article walks through the key numbers that matter. The stock has had a mixed run, with a 14.6% return over the last 30 days and a 4.2% gain year to date, set against a 9.5% decline over 1 year and deeper falls of 44.1% over 3 years and 62.0% over 5 years. These moves have kept MarketAxess on the radar for investors who follow how electronic bond trading platforms are priced and used,...